Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 59,576 shares at $7.45 ($437K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Open-market sale of $437k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.45 | 9,583 | $71K | 16.3% |
| 2 | $7.45 | 9,583 | $71K | 16.3% |
| 3 | $7.30 | 12,869 | $94K | 21.5% |
| 4 | $7.30 | 12,869 | $94K | 21.5% |
| 5 | $7.24 | 7,336 | $53K | 12.2% |
| 6 | $7.24 | 7,336 |
| $53K |
| 12.2% |
| Total | $7.33 avg | 59,576 | $437K | 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |